PURPOSE: To measure the anterior chamber depth (ACD) with 2 different devices before and after photorefractive keratectomy (PRK). DESIGN: Noncomparative case series. PARTICIPANTS: One hundred forty-three eyes of 143 patients who had undergone PRK with refractive errors ranging from -13.13 diopters (D) to +7 D (mean, -3.67+/-3.58) were analyzed. METHODS: The ACD values preoperatively and at 1, 3, and 6 months postoperatively were measured with the Orbscan II and IOL Master. The results were analyzed using the Pearson correlation. MAIN OUTCOME MEASURE: Anterior chamber depth. RESULTS: The instruments showed good agreement between the measurements before and after surgery. A significant decrease between the preoperative and 1-month postoperative measurements was found in the ACD measured from the epithelium with Orbscan II (P<0.01) and IOL Master (P<0.01). A nonsignificant decrease with both IOL Master (P>0.01) and Orbscan II (P>0.01) was found between 3 and 6 months after surgery. The ACD measured from the endothelium using the Orbscan II showed a significant difference only between the 3- and 6-month follow-up data (P<0.01). CONCLUSIONS: The 2 devices showed good agreement, and the changes detected postoperatively seem to be related not only to corneal thinning but also to anterior segment remodeling.
PURPOSE: To measure the anterior chamber depth (ACD) with 2 different devices before and after photorefractive keratectomy (PRK). DESIGN: Noncomparative case series. PARTICIPANTS: One hundred forty-three eyes of 143 patients who had undergone PRK with refractive errors ranging from -13.13 diopters (D) to +7 D (mean, -3.67+/-3.58) were analyzed. METHODS: The ACD values preoperatively and at 1, 3, and 6 months postoperatively were measured with the Orbscan II and IOL Master. The results were analyzed using the Pearson correlation. MAIN OUTCOME MEASURE: Anterior chamber depth. RESULTS: The instruments showed good agreement between the measurements before and after surgery. A significant decrease between the preoperative and 1-month postoperative measurements was found in the ACD measured from the epithelium with Orbscan II (P<0.01) and IOL Master (P<0.01). A nonsignificant decrease with both IOL Master (P>0.01) and Orbscan II (P>0.01) was found between 3 and 6 months after surgery. The ACD measured from the endothelium using the Orbscan II showed a significant difference only between the 3- and 6-month follow-up data (P<0.01). CONCLUSIONS: The 2 devices showed good agreement, and the changes detected postoperatively seem to be related not only to corneal thinning but also to anterior segment remodeling.
Authors: Alberto Domínguez-Vicent; Cari Pérez-Vives; Teresa Ferrer-Blasco; Santiago García-Lázaro; Robert Montés-Micó Journal: Int J Ophthalmol Date: 2016-07-18 Impact factor: 1.779
Authors: Maddalena De Bernardo; Luigi Capasso; Luisa Caliendo; Francesco Paolercio; Nicola Rosa Journal: Biomed Res Int Date: 2014-07-21 Impact factor: 3.411
Authors: Bu Ki Kim; Su Joung Mun; Young Hoon Yang; Ji Sun Kim; Jun Hyung Moon; Young Taek Chung Journal: BMC Ophthalmol Date: 2019-12-11 Impact factor: 2.209